Precision medicine still developing 10 years after genome is mapped

04/18/2013 | HealthDay News

A decade after the Human Genome Project's completion, scientists have an improved understanding of nearly 5,000 diseases but personalized treatments for a relative handful. Ten years ago, four FDA-approved labels included information on genetics, and now the figure exceeds 100. Genes operate in networks, making development of targeted therapies elusive, says Eric Schadt, chairman of genetics and genomic sciences at Mount Sinai Icahn School of Medicine. "We keep learning how much we really don't know and how much further we need to go," Schadt said.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ